Clinical Trial Update: A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of halobetasol propionate lotion 0.05% in plaque psoriasis has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• Halobetasol Propionate Lotion 0.05% (halobetasol propionate lotion 0.05%)

Snippet

Sponsor: Therapeutics, Inc. | Conditions: Psoriasis, Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2016-04-11